Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease
(Q46432570)
scientific article published in January 2005
scientific article published in January 2005
Language:
other details
| description | scientific article published in January 2005 |
External Links
| (P356) |
10.1016/J.MEHY.2005.01.016
|
| (P698) |
15823718
|